In Silico Identification of a Potential Multi-Target Natural Compound Against Oral Cancer

Oral cancer remains a significant global health problem due to delayed diagnosis and limited treatment effectiveness. This study employed an integrated in silico approach to identify potential natural compounds from the family Ganodermataceae, targeting chemokine receptors CXCR3, CXCR4 and CXCR7. A library of 1300 mushroom-derived compounds was screened using a ligand-based pharmacophore. The best hits were subjected to molecular docking. The computational candidate, (+)-Applanatumol D, was further evaluated using ADMET, DFT, 200 ns MD simulations and MM-GBSA. Molecular docking predicted interactions of (+)-Applanatumol D with all three receptors, ranging from −8.0 to −8.5 kcal/mol, with these values interpreted as relative computational docking scores rather than experimentally determined binding affinities. Molecular dynamics simulations showed receptor-dependent structural deviations, with greater deviations observed for the CXCR7 complex. ADMET predictions indicated favourable predicted drug-likeness characteristics, including high drug-likeness characteristics like high predicted gastrointestinal absorption alongside model-dependent toxicity predictions. Collectively, the results identify (+)-Applanatumol D as a promising multi-target computational candidate for further investigation against CXCR3, CXCR4, and CXCR7. The predicted interactions are consistent with potential receptor binding; however, whether (+)-Applanatumol D acts as an agonist or antagonist and its effects on receptor expression and oral cancer phenotypes require experimental validation.

Authors

Institutions

Publication Details

Journal
Current Issues in Molecular Biology
Published
2026-11-16
DOI
https://doi.org/10.3390/cimb48111226
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

In Silico Identification of a Potential Multi-Target Natural Compound Against Oral Cancer

Shan Sainudeen, Abosofyan Salih Atta Elfadeel, Mohasin Abdul Khader, Amani Hussain Alzubaidi et al.
4 links
Current Issues in Molecular Biology
Computational Drug Discovery Methods
article

In Silico Identification of a Potential Multi-Target Natural Compound Against Oral Cancer

Shan Sainudeen, Abosofyan Salih Atta Elfadeel, Mohasin Abdul Khader, Amani Hussain Alzubaidi, Muhammad Ishfaq, Muhammad Mudassar Saleem, nada ALhussain, Imran Khalid, Muhammad Asim Naqash, Chidozie Ifechi Onwuka
article en

Abstract

Oral cancer remains a significant global health problem due to delayed diagnosis and limited treatment effectiveness. This study employed an integrated in silico approach to identify potential natural compounds from the family Ganodermataceae, targeting chemokine receptors CXCR3, CXCR4 and CXCR7. A library of 1300 mushroom-derived compounds was screened using a ligand-based pharmacophore. The best hits were subjected to molecular docking. The computational candidate, (+)-Applanatumol D, was further evaluated using ADMET, DFT, 200 ns MD simulations and MM-GBSA. Molecular docking predicted interactions of (+)-Applanatumol D with all three receptors, ranging from −8.0 to −8.5 kcal/mol, with these values interpreted as relative computational docking scores rather than experimentally determined binding affinities. Molecular dynamics simulations showed receptor-dependent structural deviations, with greater deviations observed for the CXCR7 complex. ADMET predictions indicated favourable predicted drug-likeness characteristics, including high drug-likeness characteristics like high predicted gastrointestinal absorption alongside model-dependent toxicity predictions. Collectively, the results identify (+)-Applanatumol D as a promising multi-target computational candidate for further investigation against CXCR3, CXCR4, and CXCR7. The predicted interactions are consistent with potential receptor binding; however, whether (+)-Applanatumol D acts as an agonist or antagonist and its effects on receptor expression and oral cancer phenotypes require experimental validation.

Current Issues in Molecular BiologyVol. 48(11)
Ministry of Health (SA), King Khalid University (SA)
King Khalid University
Good health and well-being
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon